In Vitro Equivalence Testing of Amlodipine Besylate Tablets under BCS-Based Biowaiver Conditions
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: QUIZON, Paul Marvin (University of the Philippines Manila, College of Pharmacy, Manila, Philippines)
At present, bioequivalence testing involving pharmacokinetic endpoints is the generally accepted method of demonstrating therapeutic equivalence and drug product interchangeability. However, the disadvantages associated with in vivo studies brought about the development of in vitro equivalence testing and biowaivers based on the The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.